April 2024
1. GELBART B, Shann F
   The combination of systemic corticosteroids and inhaled adrenaline for bronchiolitis.
   Lancet. 2024;403:1335.
   

   >> Share

   
   February 2024
2. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
   The INSPIRE study: RSV infection during infancy - Authors' reply.
   Lancet. 2024;403:729-730.
   

   >> Share

   
   January 2024
3. QUINT JK, Shah PL
   What trials do and do not tell us about treatments for severe asthma.
   Lancet. 2024;403:224-226.
   

   >> Share

   
   December 2023
4. DRUCKER NA, Cox CS Jr
   Adult presentation of congenital tracheooesophageal fistula treated as asthma and recurrent respiratory infections.
   Lancet. 2023;402:2326-2327.
   

   >> Share

   
   
5. JACKSON DJ, Heaney LG, Humbert M, Kent BD, et al
   Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
   Lancet. 2023 Dec 7:S0140-6736(23)02284-5. doi: 10.1016/S0140-6736(23)02284.
   

   >> Share

   
   November 2023
6. VON KODOLITSCH Y, Kubisch C, Carrel T
   AATD as a genetic risk factor for aneurysmal disease - Authors' reply.
   Lancet. 2023;402:1626.
   

   >> Share

   
   
7. KUEPPERS F
   AATD as a genetic risk factor for aneurysmal disease.
   Lancet. 2023;402:1625-1626.
   

   >> Share

   
   
8. ALYAMI RA, Simpson R, Oliver P, Julious SA, et al
   Evaluation of the impact of letters to GP practices to promote asthma prescription uptake in school-age children during summer (TRAINS study): a pragmatic cluster-randomised controlled trial.
   Lancet. 2023;402 Suppl 1:S22.
   

   >> Share

   
   
9. GEDEON E, Henderson M, Leyland AH, Allik M, et al
   Association between care experience and mental health hospitalisation among children in Scotland, with a focus on chronic conditions (CHiCS): a population-wide longitudinal study using administrative data.
   Lancet. 2023;402 Suppl 1:S5.
   

   >> Share

   
   July 2023
10. LEVY ML, Bateman ED, Allan K, Bacharier LB, et al
    Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective.
    Lancet. 2023 Jul 19:S0140-6736(23)01358-2. doi: 10.1016/S0140-6736(23)01358.
    

    >> Share

    
    May 2023
11. DRANSFIELD MT, Stolz D
    The Lancet COPD Commission: broader questions remain - Authors' reply.
    Lancet. 2023;401:1570.
    

    >> Share

    
    
12. PETOUSI N, Pavord ID, Couillard S
    The Lancet COPD Commission: broader questions remain.
    Lancet. 2023;401:1569-1570.
    

    >> Share

    
    
13. CORREA PC
    The Lancet COPD Commission: broader questions remain.
    Lancet. 2023;401:1568.
    

    >> Share

    
    
14. GUENETTE JA, Milne KM, O'Donnell DE
    The Lancet COPD Commission: broader questions remain.
    Lancet. 2023;401:1568-1569.
    

    >> Share

    
    April 2023
15. BILLARD MN, Bont LJ
    The link between respiratory syncytial virus infection during infancy and asthma during childhood.
    Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
    

    >> Share

    
    
16. ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
    Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
    Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
    

    >> Share

    
    January 2023
17. SHTEINBERG M, Kassem S, Adir Y, Livnat G, et al
    An imaging pitfall: misdiagnosis of pulmonary embolism in a patient with advanced cystic fibrosis and bronchiectasis.
    Lancet. 2023;401:303.
    

    >> Share

    
    
18. PORSBJERG C, Melen E, Lehtimaki L, Shaw D, et al
    Asthma.
    Lancet. 2023 Jan 19:S0140-6736(22)02125-0. doi: 10.1016/S0140-6736(22)02125.
    

    >> Share

    
    September 2022
19. DANIELS JP
    COPD in Colombia.
    Lancet. 2022;400:875-876.
    

    >> Share

    
    
20. BRUSSELLE GG, Humbert M
    Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPD.
    Lancet. 2022;400:869-871.
    

    >> Share

    
    
21. STOLZ D, Mkorombindo T, Schumann DM, Agusti A, et al
    Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.
    Lancet. 2022;400:921-972.
    

    >> Share

    
    
22. THE LANCET
    COPD: from an end-stage disease to lifelong lung health.
    Lancet. 2022;400:863.
    

    >> Share

    
    
23. WATTS G
    Mark Dransfield: breathing new ideas into COPD.
    Lancet. 2022;400:879.
    

    >> Share

    
    August 2022
24. JACKSON DJ, Bacharier LB, Gergen PJ, Gagalis L, et al
    Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial.
    Lancet. 2022;400:502-511.
    

    >> Share

    
    
25. KELLY RS, Weiss ST
    Biologic therapies for asthma in underserved populations.
    Lancet. 2022;400:471-473.
    

    >> Share

    
    July 2022
26. DALZIEL SR, Haskell L, O'Brien S, Borland ML, et al
    Bronchiolitis.
    Lancet. 2022;400:392-406.
    

    >> Share

    
    May 2022
27. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    

    >> Share

    
    April 2022
28. LOMMATZSCH M, Brusselle GG, Canonica GW, Jackson DJ, et al
    Disease-modifying anti-asthmatic drugs.
    Lancet. 2022;399:1664-1668.
    

    >> Share

    
    January 2022
29. DANIELS JP
    Colombia euthanasia cases prompt regional debate.
    Lancet. 2022;399:348.
    

    >> Share

    
    October 2021
30. ASHER MI, Rutter CE, Bissell K, Chiang CY, et al
    Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study.
    Lancet. 2021;398:1569-1580.
    

    >> Share

    
    
31. PIJNENBURG MW, Nantanda R
    Rising and falling prevalence of asthma symptoms.
    Lancet. 2021;398:1542-1543.
    

    >> Share

    
    
32. JANKAUSKAITE L, Oostenbrink R
    Childhood lower respiratory tract infections: more evidence to do less.
    Lancet. 2021;398:1383-1384.
    

    >> Share

    
    
33. BUSH A, Pavord ID
    Forthcoming UK asthma guidelines: an opportunity to improve asthma outcomes.
    Lancet. 2021 Oct 14. pii: S0140-6736(21)02244.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share